microdosing glp 1 perimenopause GLP-1s: A Doctor's Guide to Gentle, Effective Metabolic Reset: Shamsah Amersi, MD: OB-GYNs MENOPAUSAL WEIGHT GAIN AND GLP1
Description
Federation WO (2022) London: World Obesity Federation
Anti-inflammatory mechanisms may play a role here, as chronic inflammation contributes to glomerular injury and tubulointerstitial fibrosis
Over five years, the researchers found: Osteoporosis developed in about 4.1 percent of GLP-1 users, compared with 3.2 percent of nonusers a roughly 29 percent higher relative risk
Chen EY, Mahurkar-Joshi S, Liu C, Jaffe N, Labus JS, Dong TS, et al
They overlap rather than compete
